Annual CAPEX
$33.73 M
-$15.22 M-31.09%
31 December 2023
Summary:
Beam Therapeutics annual capital expenditures is currently $33.73 million, with the most recent change of -$15.22 million (-31.09%) on 31 December 2023. During the last 3 years, it has risen by +$17.38 million (+106.22%). BEAM annual CAPEX is now -31.09% below its all-time high of $48.95 million, reached on 31 December 2022.BEAM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.58 M
-$384.00 K-19.58%
30 September 2024
Summary:
Beam Therapeutics quarterly capital expenditures is currently $1.58 million, with the most recent change of -$384.00 thousand (-19.58%) on 30 September 2024. Over the past year, it has dropped by -$6.37 million (-80.16%). BEAM quarterly CAPEX is now -92.71% below its all-time high of $21.64 million, reached on 30 June 2022.BEAM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$9.56 M
-$6.37 M-39.98%
30 September 2024
Summary:
Beam Therapeutics TTM capital expenditures is currently $9.56 million, with the most recent change of -$6.37 million (-39.98%) on 30 September 2024. Over the past year, it has dropped by -$28.84 million (-75.09%). BEAM TTM CAPEX is now -82.31% below its all-time high of $54.06 million, reached on 30 September 2022.BEAM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.1% | -80.2% | -75.1% |
| 3 y3 years | +106.2% | -72.7% | -77.0% |
| 5 y5 years | - | +11.1% | +19.5% |
BEAM CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.1% | +106.2% | -92.7% | at low | -82.3% | at low |
| 5 y | 5 years | -31.1% | +169.5% | -92.7% | +11.1% | -82.3% | +19.5% |
| alltime | all time | -31.1% | +169.5% | -92.7% | +11.1% | -82.3% | +45.3% |
Beam Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.58 M(-19.6%) | $9.56 M(-40.0%) |
| June 2024 | - | $1.96 M(-19.6%) | $15.94 M(-47.1%) |
| Mar 2024 | - | $2.44 M(-32.1%) | $30.15 M(-10.6%) |
| Dec 2023 | $33.73 M(-31.1%) | $3.59 M(-54.8%) | $33.73 M(-12.2%) |
| Sept 2023 | - | $7.95 M(-50.9%) | $38.40 M(-9.1%) |
| June 2023 | - | $16.18 M(+168.9%) | $42.24 M(-11.5%) |
| Mar 2023 | - | $6.02 M(-27.2%) | $47.71 M(-2.5%) |
| Dec 2022 | $48.95 M(+4.6%) | $8.26 M(-29.9%) | $48.95 M(-9.4%) |
| Sept 2022 | - | $11.79 M(-45.5%) | $54.06 M(+12.5%) |
| June 2022 | - | $21.64 M(+198.2%) | $48.05 M(+12.8%) |
| Mar 2022 | - | $7.26 M(-45.7%) | $42.59 M(-9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $46.81 M(+186.2%) | $13.37 M(+131.3%) | $46.81 M(+12.6%) |
| Sept 2021 | - | $5.78 M(-64.3%) | $41.57 M(+7.7%) |
| June 2021 | - | $16.18 M(+41.0%) | $38.61 M(+55.7%) |
| Mar 2021 | - | $11.48 M(+41.3%) | $24.79 M(+51.5%) |
| Dec 2020 | $16.36 M(+30.7%) | $8.13 M(+188.2%) | $16.36 M(+57.4%) |
| Sept 2020 | - | $2.82 M(+19.1%) | $10.39 M(+15.6%) |
| June 2020 | - | $2.37 M(-22.3%) | $8.99 M(-31.9%) |
| Mar 2020 | - | $3.05 M(+41.0%) | $13.21 M(+30.0%) |
| Dec 2019 | $12.52 M | $2.16 M(+52.2%) | $10.16 M(+27.0%) |
| Sept 2019 | - | $1.42 M(-78.5%) | $8.00 M(+21.5%) |
| June 2019 | - | $6.58 M | $6.58 M |
FAQ
- What is Beam Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Beam Therapeutics?
- What is Beam Therapeutics annual CAPEX year-on-year change?
- What is Beam Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Beam Therapeutics?
- What is Beam Therapeutics quarterly CAPEX year-on-year change?
- What is Beam Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Beam Therapeutics?
- What is Beam Therapeutics TTM CAPEX year-on-year change?
What is Beam Therapeutics annual capital expenditures?
The current annual CAPEX of BEAM is $33.73 M
What is the all time high annual CAPEX for Beam Therapeutics?
Beam Therapeutics all-time high annual capital expenditures is $48.95 M
What is Beam Therapeutics annual CAPEX year-on-year change?
Over the past year, BEAM annual capital expenditures has changed by -$15.22 M (-31.09%)
What is Beam Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of BEAM is $1.58 M
What is the all time high quarterly CAPEX for Beam Therapeutics?
Beam Therapeutics all-time high quarterly capital expenditures is $21.64 M
What is Beam Therapeutics quarterly CAPEX year-on-year change?
Over the past year, BEAM quarterly capital expenditures has changed by -$6.37 M (-80.16%)
What is Beam Therapeutics TTM capital expenditures?
The current TTM CAPEX of BEAM is $9.56 M
What is the all time high TTM CAPEX for Beam Therapeutics?
Beam Therapeutics all-time high TTM capital expenditures is $54.06 M
What is Beam Therapeutics TTM CAPEX year-on-year change?
Over the past year, BEAM TTM capital expenditures has changed by -$28.84 M (-75.09%)